User talk:Beno Marija/MitO2 MitoPedia: Difference between revisions

From Bioblast
No edit summary
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{MitoPedia
{{MitoPedia
|abbr=MitO2
|abbr=Mito-CII
|description='''Cell permeable prodrug''', composed of [[NV1641]] and [[NV118]], of the complex II substrate succinate increase ATP-linked mitochondrial respiration in CI-deficient human blood cells, fibroblasts and heart fibres.
|description='''Cell permeable prodrug''', composed of [[NV161]] and [[NV118]], of the complex II substrate succinate increase ATP-linked mitochondrial respiration in CI-deficient human blood cells, fibroblasts and heart fibres.
|info=[[MitO2-Kit]], [[Ehinger 2016 Nat Commun]]
|info=[[Mito-CII-Kit]], [[Ehinger 2016 Nat Commun]]
}}
}}
{{MitoPedia topics
{{MitoPedia topics
|mitopedia topic=Medium
|mitopedia topic=Medium
}}
}}
* For preparation of MitO2, see [[MitO2-Kit]].
* For preparation of Mito-CII, see [[Mito-CII-Kit]].

Latest revision as of 09:44, 21 March 2019


high-resolution terminology - matching measurements at high-resolution


User talk:Beno Marija/MitO2 MitoPedia

Description

Cell permeable prodrug, composed of NV161 and NV118, of the complex II substrate succinate increase ATP-linked mitochondrial respiration in CI-deficient human blood cells, fibroblasts and heart fibres.

Abbreviation: Mito-CII

Reference: Mito-CII-Kit, Ehinger 2016 Nat Commun


MitoPedia topics: Media for respirometry 

Cookies help us deliver our services. By using our services, you agree to our use of cookies.